# DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS

> **NCT06488027** · — · COMPLETED · sponsor: **AB Biotek** · enrollment: 200 (actual)

## Conditions studied

- Insomnia
- Insomnia Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06488027
- **Lead sponsor:** AB Biotek
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-05
- **Primary completion:** 2023-11-27
- **Final completion:** 2023-11-27
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06488027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06488027, "DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06488027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*